Cargando…
Low-density lipoprotein particle size in hepatic steatosis and metabolic syndrome
BACKGROUND: Hepatic steatosis (HS), the most frequent liver disorder, was reported to be an independent predictor of cardiovascular disease. HS, if combined with the metabolic syndrome (MetS), might have a synergistic effect on low-density lipoprotein (LDL) particle size. METHODS: Carotid intima-med...
Autores principales: | Kim, Dal-Sik, Kim, Young-Kon, Kim, Do-Sung, Chae, Han-Jung, Park, Tae-Sun, Cho, Young I, Jeong, Seul-Ki |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859849/ https://www.ncbi.nlm.nih.gov/pubmed/20307304 http://dx.doi.org/10.1186/1758-5996-2-18 |
Ejemplares similares
-
Low-Density-Lipoprotein Particle Size Predicts a Poor Outcome in Patients with Atherothrombotic Stroke
por: Song, Tae-Jin, et al.
Publicado: (2015) -
Lack of Association Between Low Density Lipoprotein Particle Size and On-Treatment Platelet Reactivity in Patients With Coronary Artery Disease
por: Kang, Do-Yoon, et al.
Publicado: (2012) -
Impact of Visceral Fat on the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease
por: Jeong, Seul-Ki, et al.
Publicado: (2008) -
Low Density Lipoprotein-Cholesterol/High Density Lipoprotein-Cholesterol Ratio Predicts Plaque Vulnerability in Patients With Stable Angina
por: Kim, Jeong Hun, et al.
Publicado: (2012) -
Low-Density Lipoprotein Receptor-Related Protein-1 Protects Against Hepatic Insulin Resistance and Hepatic Steatosis
por: Ding, Yinyuan, et al.
Publicado: (2016)